Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rang în acțiuni #24454
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Preț acțiune
$0.78611575
Capitalizare de piață
$60.45M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-12.06%
Țară
NO
Tranzacționează Lytix Biopharma AS (LYTIX)

Categorie

Istoricul spliturilor pentru Lytix Biopharma AS (LYTIX)
Acțiunea Lytix Biopharma AS (simbol: LYTIX) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 21, 2026.
O acțiune LYTIX cumpărată înainte de Aug 21, 2026 este echivalentă astăzi cu 0 acțiuni LYTIX.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH